Effects of Siliphos-Selenium-Methionine-Alpha Lipoic Acid in Patients With Fatty Liver and Non-alcoholic Steatohepatitis

NCT01650181 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Liver Disease

Interventions

DRUG: Metformin
DIETARY_SUPPLEMENT: Siliphos+ Selenium - Methionine + Alpha Lipoic Acid
DIETARY_SUPPLEMENT: Siliphos+ Selenium - Methionine + Alpha Lipoic Acid
DRUG: Metformin

Sponsor

Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran